---

Advertising Information | FAQs | About Us | Contact Us | Privacy Policy

---

---

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

The following Pharma Marketing Blog posts focus on issues related to pharmaceutical eMarketing, Internet, social media marketing, etc. Click on title to access full-text post in new browser window. Posted in 2009: Shire Implements First Ever Integrated Phone-Assis... Investors Have Questions About Pharma's Online Spe... Will Patients Find Value in Discussions with Pharm... Finally. Individuals Speak Out Pro & Con (Mostly C... Will Pharma Spend More on eMarketing than on TV Ad... Premature Social Media Promotion (PSMP): A New Pha... Transcripts of FDA's November 2009 Public Hearing ... Is the Pharma Social Media Bubble About to Burst? Atlas Did NOT Shrug! FDA Makes (Some) Comments Pub... Dear FDA: Where Are the Public Comments Regarding ... FDA Intern & the Next Steps Toward Pharma Social M... Is Google the New FDA? FDA Social Media Guidelines Best Done in Baby Step... FDA Social Media Hearing Day 1: My Key Takeaways I'm Off to FDA Hearing: Here's What I Plan to Show... FDA Panelists at the Upcoming Social Media Public ... PhRMA Proposes FDA-Approved Use of Universal Safe... FDA Public Hearing: Not Deja Vu All Over Again? My FDA Social Media Hearing Presentations Industry Groups will Eat Consumer Advocates' Lunch... Social Media Best Practices for Pharma Are Needed,... Expect FDA Social Media Draft Guidance Before End ... Fear and Loathing in Washington, DC Pharma Social Media Crips vs. Legal/Regulatory Blo... I Will Present Survey Results at November FDA Hear... Boehringer's Branded Tweet Violates FDA Regulation... CEI's Critique of FDA's Paid Search Stance Should ... Are There Special Cases for Correcting Misinformat... How Should Pharma Companies Submit Social Media Co... Should Pharma Companies Correct Drug Misinformatio... Is FDA's Sponsored Search Advertising Policy Incre... Pharma Companies Should Have Public Social Media D... Regulatory Solutions to Overcoming Space Limitatio... Does Social Media Have an Impact on Public Health?... Pharma Prefers "1-Click Rule" for Presenting Fair ... 3rd Party Dissemination of Altered Rx Drug Informa... Should FDA Regulation Depend on Specific Media or ... When Are Third-Party Online Discussions Not Indepe... What Criteria Determine Substantive Pharma Influen...

Special Supplement Social Media Pharma Marketing Damned If You Do, Damned If You Don't? This collection of Pharma Marketing News articles, blog posts, and survey results provides you with an excellent introduction to the many issues involved in social media pharma marketing. TABLE OF CONTENTS Order and pay for this Special Supplement now using your credit card... ONLY $29.95 Download PDF file immediately after paying: If you wish to be invoiced and/or pay by check, please use: Printable Order Form Special Supplement ePharma Marketing Many experts believe that pharma eMarketing is at a tipping point and that pharma- ceutical companies are poised to shift substantial ad spending from TV and other media to the Internet. The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement. TABLE OF CONTENTS Order and pay for this Special Supplement now using your credit card... ONLY $29.95 Download PDF file immediately after paying: If you wish to pay by check or credit card off-line, please use: Printable Order Form

• FDA Letters Caused a Prompt, Precipitous, & Prolon...
• My Opinion of Google's Decision to Foist Sidewiki ...
• Google's Wacky Wiki is Whack! Pharma Should Demand...
• What Techniques are Used by Pharma to Monitor Adve...
• Who Should Be Responsible for Submitting Adverse E...
• How is Adverse Event Information from Social Media...
• Challenges Handling Adverse Events Found on SM Sit...
• Uncertainties Regarding Reporting Adverse Events F...
• Some Pharma Marketers Can't See the Unbranded SM F...
• Internet Surpasses Newspapers in Gobbling Up the D...
• Get Your FDA Social Media Public Hearing T-Shirt!
• Are J&J Agents Trolling for Adverse Events on the ...
• My Twitter Followers: Thank You!
• Pharma Influence Over 3rd-Party Conversations in S...
• Let's Respond to FDA's Questions Regarding Its Reg...
• FDA Announces Public Hearing on Promotion of Drugs...
• An Example of Non-Transparency Over at FDA's Trans...
• Are Organic Search Results Next on FDA's Chopping ...
• What Do Phone Sex, the Pittsburgh Symphony Orchest...
• Twitter's for the Dogs! ... and Other "Indirect Cu...
• Twitter for Patient Support: Not as It Is, but as ...
• Full BOEHR(inger) Social Media Reporting of RELY T...
• Twitter for Brands: Beyond Marketing
• Twitter and Drug Safety: A Paramount Concern
• Charlie Kimball, Novo Nordisk, and Me Make Up
• Novo to Social Media: Report the Facts
• On Twitter, A Patient Photo is Worth a Thousand Ch...
• The Social Media Revolution Will Not Be "Televised...
• Pfizer's Social Media Strategy: Piss Off John Mack...
• When is it Acceptable for Pharma Marketers to Use Behavioral Targeting?
• Summertime and Twitter is Easy
• Can Pharma Use Social Media to Provide Patient Sup...
• A "Hubble" View Into the Pharma Cosmos
• Genuine Conversation: The Big Kahuna of Social Med...
• What ePharma Pioneers Can Teach Today’s eMarketers
• Thank You Johnson & Johnson for Dinner
• Let's Make it a Threesome: One Other Social Media Activity Pharma Can Do Now!
• Missing Warning Letters Prove that FDA is an Internet Dunce!
• Internet Advertising Has Stopped Dead in Its Tracks!
• Missing FDA Letters Found. More Questions.
• Regulatory Ranters Miss the Point About FDA's Position on Search Engine Ads
• Finally, a Drug Company Embraces Social Media, AEs Included!
• Procter and Gamble's Dysfunctional Asacol Community for UC Patients
• Novo Nordisk's Branded (Levemir) Tweet is Sleazy Twitter Spam!
• Pharma Marketers Should Stop Blaming the FDA for Their Dysfunctional Social Media Marketing Efforts
• Nasonex Bee May Usher In a Whole New Way to do FDA-friendly Pharma Tweets
• Novo Nordisk Selectively Copies & Edits Kimball's Tweets
• Marketing Mix of Leading Pharma Advertisers in 2008
• My First Tweetup! A Good Idea for Pharma Media Relations People
• Acromegaly Answers Blog Raises Interesting Regulatory Question
• Does Novo's Editing Suck the Life Out of Charlie Kimball? Yes, by Some Objective Measures.
• Quality Healthcare Social Media: Separating the Wheat from the Chaff
• Academics Exaggerate, Journalists Regurgitate. What About Bloggers?
• Social Media: Ask Permission to Join the Conversation First or You Just Might Get Your Ass Kicked!
• Online Advertising Growth Slows in 2008, Search Declines in 2009
• 65% of Psychiatrists Say "NO" to Pharma on Facebook!
• Cheerios vs. the One-Click Rule: Are FDA's Priorities "Askew?"
• Consumer Opinion Leaders: Pharma's Secret Sauce for Social Media Marketing
• Will the Drug Industry be the Next Auto Industry?
• The Real Agenda of GSK's New Blog and Why the Authors' Identities are Cloaked
• Towards a Rational FDA Policy Addressing the Internet and Social Media
• Arnold Friede Blasts FDA's Right to Define "Reasonable Man" Without External Input
• Uh, Oh! Will FDA Cite this "One-Click Rule" Twitter Post by AZ as Violative?
• Communicating Risk in Online Drug Ads: Reading the Tea Leaves in Recent FDA Draft Guidance
• Dear GSK: Precedent Should Not Guide Pharma's New Media Communications Strategy
• Social Media: Opportunity or Nightmare?
• 50 Ways to Use Social Media
• Pharma Agency Awards for Web 1.0, None for Blogs or Other Social Media
• Is Pharma Socially Challenged?
• What Good Can Come from a Public FDA Hearing on Social Media?
• How to do Social Media Pharma Marketing without Getting Blown Up
• FDA, Tear Down This Wall! A Draft Petition Calling for a Public Hearing
• Twitter Lobbying Effort Calls Upon FDA to Convene a Public Hearing
• Redirect URLs in Adwords: Who Knew What When?
• St. Google Slays the FDA Dragon?
• The Next FDA Concern May be the Use of "Redirect" URLs
• PhRMA Says FDA Should Initiate a Public Process Rather than Regulate by Warning Letter When it Comes to the Internet
• When it Comes to Pharma Marketing on the Internet, be Careful of the Advice You Get from "Experts"
• The 14 Letters. Who at the FDA Knew What and When? FDA Intern Wants to Know!
• There's a New Crop of Pharma People Who Are Not So Savvy About Social Media!
• Pharma's "Social Media Readiness" Score Improves
• FDA's Actions Speak Louder than Its Words: On the Internet It's the Medium as Well as the Message!
• Quality Healthcare Social Media: Separating the Wheat from the Chaff
• FDA and Pharma - Bring More Stakeholders into Your Discussion of Social Media Guidelines! No More Joking!
• FDA Issues First-ever Draft Guidance on Pharma’s Use of Social Media!
• Faux Social Marketing: Have Your Cake and Eat It Too!
• Dis RealAge All You Want NY Times, But Consumers Want those E-mails from Pharma Companies!
• Update on that YAZ YouTube Video
• Pharma Reps' Worst Fear Is Near: Outsourced to the Internet!
• Pharma Dreams of Dipping Its Toe Into Social Networking Waters
• FDA's Answer to ePharma Marketing Guidelines: "circles and arrows and a paragraph on the back"
• Tit-for-Tat Tithe on Pharma Marketing. How It Can Work.
• Follow Who's Following Me on Twitter. But NOT Phishy "pfizer" Please!
• Why It's Important to Monitor & Engage in Social Media
• Debbie Phelps Purged from McNeil's ADHD Moms™ Facebook Group. How Cruel!
• Report from CBI's eMarketing Forum: Taking on the AE Boogey Man
• Report from CBI's eMarketing Forum: Preaching to the Choir
• CNTO411: We'll Meet Again, Don't Know Where, Don't Know When
• Pharma Dreams of Dipping Its Toe Into Social Networking Waters
• FDA's Answer to ePharma Marketing Guidelines: "circles and arrows and a paragraph on the back"
• You Must Score Better than 84% on Viagra's Sexual Health Quiz to NOT Have Signs of ED
• New "New Media" Trick for Pharma Marketers
• Online Personal Health Records and Pharma Search Engine Marketing
• Not Your Father's SEM! YouTube Empowered and Geo Targeted, Just to Name a Few New Things to Consider
• YAZ Commercial Yanked from TV, But Not from YouTube
• 10 Things I Hated (and Loved) about the ePharma Summit
• ePharma Summit: Practicing What's Being Preached!
• New Media, Old Regulations: Like Oil and Water, They Don't Mix!
• The Real Reason Why Pharma Hates Social Media Marketing
• CNTO411 Blog to Go Dark
• Emerging Search Engine Technology Drives Digital Integration
• "Corporate Blog" is an Oxymoron
• New Year's Resolutions for Pharma Marketers

Posted in 2008:

• The Problem with Social Networks: Where's the Wisdom in 1% of a Crowd?
• Death of the One-Click "Rule" or "Received Precedent" or Whatever!
• Despite FDA Warning Letter, YAZ Web Site Still Connects YAZ with Treatment of Acne!
• Microsoft Claims Web Searches Bad for Your Health?
• FYI: Centocor Launches New Web Site to Help Physicians Converse with Patients About Remicade
• King of the Hill Blasts Social Network Marketing: Lessons for Pharma
• Alice, 35, is Not a Real Ambien CR Patient.
• eMarketers Make a Comeback Inside Pharma
• Do Privacy Concerns Stand in the Way of Measuring Pharma eMarketing ROI?
• PhRMA Intern and the YouTube Guru
• J&J, Debbie Phelps, You, Me, Facebook: Is This Social Networking?
• Social Marketing Pharma Style
• New Image for alliconnect Blog: Skinny Women
• New alli Plan to Gain Market Share: Eliminate the Competition!
• The alli lesson: Pharma marketing is not ready for transparency
• Social Media Marketing Not All It's Cracked Up to Be
• Blogs are Done! What’s Next for Pharma Marketing?
• Internet vs. Sales Reps: Which Do Docs Prefer?
• Pharma Online Ad Bellwether WebMD Foresees Ad Slowdown
• Violative Viva Viagra Video - Still There!
• The Real Value of Blogs for Marketing Is...
• Pharma Ad Spending Shrinking!
• Centocor: Let Thy Employees Speak!
• Do You Have the "Legs" to Engage in Social Media Marketing?
• Overcoming Pharma's Employee Blogging Fears
• Pharma Recession, Part Deux: Online Ad Spending Sinking!
• I'm All a Twitter Over Twitter! Viral Social Marketing at Its Best?
• CNTO411: Centocor's Groundbreaking Blog
• Social Media to Congress: "Piss Off!"
• What's Your Social Media Readiness Score?
• World Without Broadcast DTC Would be a Boon to eMarketing
• Helping Pharma eMarketing "Grow Up"

Posted in 2007:

• The "One-Click Rule": Rant or No Rant?
• Online CME Growth is Bad News for Pharma Marketers
• J&J Blog, Shire PR: The Whole Story and Nothing But the Whole Story!
• Pharma Grapples with Barriers to Adopting Web 2.0
• Sermo CEO Talks About Pfizer Collaboration
• Pfizer Facebook a la Sermo?
• Web 2.0 Pharma Marketing Tricks for Dummies
• My Prediction Vindicated: FluFlix Contest Entrants Will Sign Over Video Rights
• Novartis Attempts Perfect Execution of Web 2.0 Trick!
• Wikis and Social Networks for Marketing & Sales Collaboration: Will It Work?
• Rozerem's Cheapskate Sweepstakes Violates Children's Online Privacy Protection Act
• Social Network Analysis Good for Obesity Drug Marketing and Beyond!
• Advice to All Pharma PR Bloggers Out There
• Is Advertising Democratic? Girl from Google Thinks So!
• Rejiggering the Marketing Mix a la Merck
• Google's "Old School" Health Advisory Council
• Pharma Online Marketing: Got Game?
• Cause Marketing via YouTube: What Pharma Can Learn from Michael Moore
• GSK's YouTube Disease Awareness Sponsorship
• Blogs vs. DTC: What's Best for Consumers?
• Blogs Critical of Drug Industry Are Most Credible, Says Survey
• A Few Rules for Pharma Employee Blogging
• Web 2.0 Hates Sally
• Merck's Refreshing Director of Global eMarketing
• Marketing Drugs to Teens Online - So Wrong!
• First Ever Pharma Blogosphere Survey!
• Revolution Health and the Wisdom of Crowds
• Banned from CafePharma!
• Web 2.0 for Pharma Marketing Podcast
• Brave New Pharma?
• YouPharma(tm): A Brave New World of Marketing?

Posted in 2006:

For access to the following posts, please use the Monthly Archive.

• What Was Blogworthy in 2006? A Review
• Where's DDMAC's Head At?
• Celebrex Joins the bAdWord Bandwagon!
• Physician Blogging - Survey Results
• Compliance, Math, and Marketers
• Out with the Bad, In with the Good
• Chantix: Opportunity for Social Marketing Lost?
• Not Your Father's eDetail
• The "Girl from Google"
• Influencing the Dialogue: Marketers Suck at It!
• Upcoming "Pharma Marketing Talk" Podcast
• What a Difference a Day Makes!
• Clear Words, Obscure Benefits
• Lunesta, Google, and "bAdWords"
• AmbienCR and Lunesta Duke It Out on Web
• CGC: Old Wine in New Bottles
• Product Web Sites Not Up to Par
• (¼±»ý´Ô) Á¤Ç°100%!! ºÒ [Spam DTC Ad]
• Pharma eMarketing in a Slump
• Rozerem Beaver Buzz
• Health Literacy - Words Fail to Tell the Story
• Web DTC Video: Boon or Bane?
• Marketing plan A for Plan B
• Precision Buzz Marketing
• Anonymous Online Marketing
• Rules of Engagement
• Rozerem Ads Dis Lincoln, Show Beaver
• Question Everything
• The Marketing Mix Maze
• Behavioral Targeting: RJ vs JP
• How Not to Influence Physician Bloggers
• Buzz 'n Blogs -- Stealth Marketing
• Immutable Laws of DTC Domain Naming
• Paid Inclusion: Too Hot for Pharma Marketing?
• Cialis Blog Shut Down
• Cialis Blog -- Shame on Lilly ICOS

Posted in 2005:

For access to the following posts, please use the Monthly Archive.

• Coming Soon: Sexy eDetailing
• eDetailing: Surveys Say...
• Online Marketing Ethics, Part 1
• Are Pharma Ad $ Moving Online?
• Alternative to DTC: cDetailing
• Internet Marketing: Risks Ahead
• Bloggers Worry Pharma More Than FDA
• Pharma eMarketing at Tipping Point?
• eDetailing ROI Better Than DTC?
• Pull Back from DTC on TV?
• Innovative Drugs Deserve Innovative Marketing
• DTC in 2005: Old Dogs, New Tricks?